BTIG upgraded Synchrony Financial (NYSE:SYF) and Bread Financial (NYSE:BFH) to Buy, Ally Financial (NYSE:ALLY) to Neutral and ...

As of Monday, the S&P 500 has been trading above its 20-day moving average for 55 days. That's the longest stretch since ...

I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision ...

BTIG downgraded shares of Affirm and PROG Holdings ahead of second-quarter earnings, flagging concerns over weakening credit trends and increased competition from traditional lenders. Brokerage ...

BTIG downgraded AFRM to "neutral" from "buy" Though shares of buy-now-pay-later name Affirm Holdings Inc (NASDAQ:AFRM) have ...

Billionaire Kerr Neilson has bought over $8 million worth of shares in Flutter Entertainment plc (NYSE:FLUT), representing ...

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

BTIG to provide strategic advice on capital markets positioning, institutional engagement, and investor outreachAppointment ...

BTIG sees increased stability for the medtech sector in 2024 as it moves past concerns about the impact of GLP-1 weight-loss drugs, supply chain snarls, and higher interest rates. “With GLP-1 ...

BTIG made the claim in a lawsuit filed late Monday in California state court and seeks at least $200 million in damages. Have a confidential tip for our reporters? Get in Touch.

Nov 13 (Reuters) - U.S. brokerage firm BTIG on Monday sued rival StoneX Group Inc , opens new tab in San Francisco, accusing it of stealing trade secrets and seeking at least $200 million in damages.

BTIG has a "buy" rating on the stock, and a price target of $150. That's based on "high single-digit revenue growth," Expedia's EBITDA margin expanding to more than 23%, ...